Missing 30 minutes of sleep on weekdays linked to obesity, insulin resistance
the ONA take:
According to a preliminary findings presented Thursday at the annual meeting of the Endocrine Society in San Diego, California, researchers have found that missing just 30 minutes of sleep during weeknights could increase a person's weight and disrupt metabolism.
For the study, researchers enrolled 522 with newly diagnosed type 2 diabetes and randomly assigned them to usual care, added exercise, or diet and exercise.
When the study began, researchers found that those who did not get enough sleep on weeknights were 72% more likely to be obese than those who got sufficient sleep.
After 6 months, researchers found that participants who did not get sufficient sleep were more likely to be obese and have problems with blood sugar.
Specifically, researchers found that missing just 30 minutes of sleep during weeknights was enough to cause issues. For every 30 minutes of sleep missed on weekdays, the risk of obesity was increased by 17% and the risk of insulin resistance was elevated by 39%.
Missing just 30 minutes of sleep during weeknights could increase a person's weight and disrupt metabolism.
Sign Up for Free e-newsletters
- Risk Factors for Arterial, Venous Thrombosis Differ in Polycythemia Vera
- Dietary Estrogens Reduced Efficacy of Novel Breast Cancer Therapy
- Patient Satisfaction Ratings Can Be Negatively Impacted by Nurse Staffing Ratio
- BRCA Mutation Improves Prognosis for 2-year Survival in Younger-onset TNBC
- Fosfomycin Effective Alternate for Febrile Neutropenia Prophylaxis
- Pertuzumab Regimen Approved for Adjuvant, Neoadjuvant Therapy in Specific Breast Cancers
- Common Oncologic Emergencies That Occur With Multiple Myeloma
- Artificial Sweeteners and Cancer Risk (Fact Sheet)
- Blueberry Extract May Boost Efficacy of Radiotherapy for Cervical Cancer
- Breast Implants Associated With Increased Risk of Breast Anaplastic Large-cell Lymphoma
- Resolving Vaginal Dryness in Women With a History of Breast Cancer
- Overall Survival Prolonged With HIPEC + Cytoreductive Surgery for Gastric Cancer
- Better Postoperative Outcomes With RAMIE for Esophageal Cancer
- Distinct Patterns of Shiny White Streaks Strong Indicator of Melanoma
- FDA Issues Warning for Rolapitant Injectable Emulsion in the Treatment of CINV
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|